Swiss Biotech Stock News

SWX:UHR
SWX:UHRLuxury

Swatch Group (SWX:UHR) Valuation After Rebound In Sentiment And 2026 Growth Outlook

Why Swatch Group Stock Is Back on Investors’ Radar Swatch Group (SWX:UHR) moved into focus after management reported stronger sales momentum in late 2025, projected substantial growth for 2026, and kept its dividend unchanged despite a sharp profit decline. See our latest analysis for Swatch Group. The latest earnings update and dividend decision have shifted attention back to the share price, which has reacted sharply in the short term. Swatch Group’s 1 day share price return of 13.42% and 7...
SWX:LAND
SWX:LANDElectronic

A Look At Landis+Gyr Group’s Valuation As Mitsubishi Electric Partnership Advances Grid Edge Plans

Mitsubishi Electric Corporation and Landis+Gyr Group (SWX:LAND) have signed a Memorandum of Understanding to work together on grid edge intelligence and energy transition solutions, initially targeting North American utilities. See our latest analysis for Landis+Gyr Group. The Mitsubishi Electric agreement lands after a recent Q3 sales or trading statement call and comes as the share price sits at CHF54.3, with a 7 day share price return of 6.68% but a 1 year total shareholder return of 8.23%...
SWX:BEAN
SWX:BEANBuilding

Did BELIMO’s 23.3% Sales Surge in 2025 Just Shift BELIMO Holding's (SWX:BEAN) Investment Narrative?

In January 2026, BELIMO Holding AG reported its 2025 results, revealing accelerated sales growth of 23.3% in local currencies and CHF 1,121 million in sales. This sharp step-up in growth relative to the prior year highlights how BELIMO’s offering is gaining traction across its key end markets. We’ll now examine how this acceleration in sales growth shapes BELIMO’s investment narrative and what it could mean for investors. The end of cancer? These 29 emerging AI stocks are developing tech...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Is Up 10.4% After New Buyback And Record Q4 2025 - Has The Bull Case Changed?

ABB Ltd has completed its 2025 share buyback, reported record fourth-quarter 2025 results with higher revenue and earnings, and announced a new US$2.00 billion share repurchase program running through January 27, 2027 for capital reduction and employee share plans. The company coupled the buyback with guidance for comparable revenue growth of 7%–10% for the first quarter and 6%–9% for full-year 2026, highlighting confidence backed by a record order backlog and expanding electrification and...
SWX:BUCN
SWX:BUCNMachinery

A Look At Bucher Industries (SWX:BUCN) Valuation After Cost Controls Property Sale And CEO Transition

Bucher Industries (SWX:BUCN) is back in focus after recent updates on cost controls, a one off property sale, and leadership changes, including a new CEO, accompanied by guidance for an operating margin around 8%. See our latest analysis for Bucher Industries. Despite the recent focus on cost controls, a one off property sale and leadership changes, Bucher Industries’ 1 year total shareholder return is only slightly positive at 0.52%, while the 3 and 5 year total shareholder returns of 6.71%...
SWX:PGHN
SWX:PGHNCapital Markets

Assessing Partners Group Holding (SWX:PGHN) Valuation After Its New Multi Alternatives SMA With BlackRock

Why the new multi alternatives SMA launch matters for Partners Group Holding (SWX:PGHN) Partners Group Holding (SWX:PGHN) has drawn fresh attention after teaming up with BlackRock to launch a multi alternatives separately managed account that packages private equity, private credit, and real assets into a single-access solution. See our latest analysis for Partners Group Holding. The SMA launch comes as Partners Group Holding’s share price shows a 6.88% 1 month gain and an 8.14% 3 month share...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG) Net Margin Jump To 20.3% Tests Long Term EPS Bear Case

How Roche Holding (SWX:ROG) Just Framed Its FY 2025 Story Roche Holding (SWX:ROG) opened FY 2025 with first half revenue of CHF31.8b and basic EPS of CHF9.31, setting the tone with headline numbers that put both the top line and per share earnings clearly on the radar for investors following this latest update. Over the recent reporting periods, revenue has moved from CHF30.8b in the first half of 2024 to CHF31.6b in the second half and then to CHF31.8b in the first half of 2025. Basic EPS...
SWX:BARN
SWX:BARNFood

Cocoa Volume Slump And Value Focus Might Change The Case For Investing In Barry Callebaut (SWX:BARN)

In late January 2026, Barry Callebaut reported a 22% decline in cocoa division sales volume for the quarter ended November 30, citing weak global demand and a tilt toward higher-return product segments against a backdrop of abundant cocoa supplies and pressured prices. This combination of softer end-consumer appetite for chocolate and a deliberate focus on more profitable cocoa uses signals an important shift in how Barry Callebaut is balancing volume and value across its business. We will...
SWX:UBSG
SWX:UBSGCapital Markets

What UBS Group (SWX:UBSG)'s Push Into Crypto Trading and Premium Advisory Means For Shareholders

UBS has promoted long-time banker Nicholas Hinnen to the newly created role of head of premium advisory specialists APAC Switzerland and is also preparing to let select clients trade bitcoin and Ether, expanding its digital asset offering across regions. Together, the leadership move in ultra-wealth advisory and the planned crypto trading program highlight UBS’s push to refine high-end client services while responding to evolving digital asset demand. Next, we’ll consider how UBS’s move into...
SWX:UBXN
SWX:UBXNSemiconductor

A Look At u‑blox Holding (SWX:UBXN) Valuation As AI Demand And Earnings Outlook Draw Attention

AI driven demand puts u-blox Holding (SWX:UBXN) in focus ahead of earnings Market attention has turned to u-blox Holding (SWX:UBXN) as investors weigh its role in AI related GNSS and wireless modules, and look ahead to earnings, with revenue mix and margin recovery under scrutiny. See our latest analysis for u-blox Holding. After a strong run, with an 81.21% year to date share price return and a 108.01% total shareholder return over the past year, recent gains around AI related GNSS demand...
SWX:LOGN
SWX:LOGNTech

Assessing Logitech International (SWX:LOGN) Valuation After Q3 Earnings Beat And Share Price Pullback

Logitech International (SWX:LOGN) is back in focus after third quarter results paired solid sales and income figures with a 6.4% share price drop, as investors weighed cost pressures and tariff related risks. See our latest analysis for Logitech International. Those Q3 results and fresh guidance landed against a weak recent run, with a 30 day share price return of 18.27% and a 90 day share price return of 32.44%. The 1 year total shareholder return of 26.10% contrasts with a 3 year total...
SWX:UHR
SWX:UHRLuxury

Why Swatch Group (SWX:UHR) Is Up 10.2% After Holding Its Dividend Amid Earnings Slump

Swatch Group reported full-year 2025 results with sales of CHF 6,280 million and net income of CHF 3 million, and also affirmed an annual dividend of CHF 4.50 per share payable in May 2026. Despite the sharp earnings drop, management’s decision to maintain production capacity, protect jobs, and keep the dividend highlights a long-term confidence in future demand. With recent results showing improving sales momentum, we’ll explore how Swatch Group’s decision to preserve capacity and its...
SWX:NESN
SWX:NESNFood

Assessing Nestlé (SWX:NESN) Valuation After Baby Formula Toxin Recalls And Intensifying Regulatory Scrutiny

Regulators have confirmed a food poisoning toxin in some Nestlé (SWX:NESN) baby formula products, prompting recalls and investigations that are now central to how investors assess the company’s risk profile and potential reputational overhang. See our latest analysis for Nestlé. The recent baby formula recalls and food safety investigations come after a period where Nestlé’s 30 day share price return of 6.74% decline and 90 day share price return of 4.49% decline have weighed on sentiment,...
SWX:HUBN
SWX:HUBNElectrical

Does Huber+Suhner's (SWX:HUBN) Stable Margin Guidance Outweigh Its Dip In 2025 Net Sales?

In January 2026, Huber+Suhner AG reported unaudited 2025 net sales of CHF 864.1 million, compared with CHF 893.9 million in the prior year. At the same time, the company confirmed guidance for a 2025 operating profit margin of 10–11%, suggesting a focus on maintaining profitability despite slightly lower sales. We will now examine how the confirmed 10–11% EBIT margin guidance shapes Huber+Suhner’s investment narrative following these latest results. We've found 14 US stocks that are...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG) Valuation After CT-388 Obesity Data Earnings Strength And Dividend Proposal

Roche Holding (SWX:ROG) is in focus after reporting full year 2025 earnings alongside standout Phase II data for its obesity candidate CT-388 and proposing a higher dividend, a combination that sharpens attention on its cardiometabolic ambitions. See our latest analysis for Roche Holding. The latest CT-388 data and dividend proposal come after a strong run in the share price, with a 90 day share price return of 35.46% and a 1 year total shareholder return of 26.68%. This suggests momentum has...
SWX:BEAN
SWX:BEANBuilding

A Look At BELIMO Holding’s Valuation After Accelerating 23.3% Sales Growth In 2025

Why BELIMO Holding’s latest sales update matters for investors BELIMO Holding (SWX:BEAN) has drawn fresh attention after reporting 2025 revenue of CHF 1,121 million, with sales growth of 23.3% year-on-year in local currencies, compared with 13.1% in 2024. See our latest analysis for BELIMO Holding. The latest sales update arrives as BELIMO Holding’s share price trades at CHF 845.0, with a 30‑day share price return of 8.19% and a 1‑year total shareholder return of 28.44%. This suggests...
SWX:AMRZ
SWX:AMRZBasic Materials

Is Amrize’s (SWX:AMRZ) Q4 Earnings Call Set To Reframe Its Long-Term Growth Narrative?

Amrize has announced it will release its fourth-quarter 2025 results after the U.S. market closes on February 17, 2026, followed by a webcast the next morning to discuss the numbers with investors. Fresh analyst coverage, including updated ratings and commentary, is sharpening market attention on how these upcoming results could shape perceptions of Amrize’s outlook. We’ll now examine how the upcoming fourth-quarter earnings release and related analyst commentary may influence Amrize’s...